Palor, Agustin R.
HRN: 22-05-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/10/2022
10/17/2022
IV
2.25g
Q12h
Snake Bite
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes